Affiliation:
1. Department of Chemistry, Institute of Conju-Probe, San Diego, California, USA
2. Department of Chemistry, Bharath
University, Chennai, Tamil Nadu, 600126, India
Abstract
Abstract:
The present disclosure relates to p38α mitogen-activated protein kinase
inhibitors, pharmaceutical compositions thereof, and the use of the p38α mitogen-activated
protein kinase inhibitors and pharmaceutical compositions thereof for treating various diseases
such as cancer, rheumatoid arthritis, amyotrophic lateral sclerosis, cystic fibrosis, cardiovascular
disease, multiple sclerosis, inflammatory bowel disease, chronic obstructive pulmonary disease
(COPD), asthma, COVID-19, acute respiratory distress syndrome (ARDS), and acute lung injury
(ALI).
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Cancer Research,Drug Discovery,Oncology,General Medicine
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献